64 related articles for article (PubMed ID: 3091882)
1. [Prevention of cancer chemotherapeutic agent-induced toxicity in postoperative breast cancer patients with glycyrrhizin (SNMC)].
Akimoto M; Kimura M; Sawano A; Iwasaki H; Nakajima Y; Matano S; Kasai M
Gan No Rinsho; 1986 Jul; 32(8):869-72. PubMed ID: 3091882
[TBL] [Abstract][Full Text] [Related]
2. [Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer (Part 1). Comparison between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy)].
Arima S; Simura H; Yamanouchi A; Fukuyama N; Hisatsugu T; Yamamoto H; Ohsato K; Ohkuma R; Nakamura Y; Abe R
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2524-31. PubMed ID: 3113340
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin: its evolving role in the treatment of breast cancer.
Hortobagyi GN
Oncology; 1993 Apr; 50 Suppl 1():1-8. PubMed ID: 8483556
[TBL] [Abstract][Full Text] [Related]
5. [The effect of cepharanthin on adjuvant chemotherapy induced bone marrow suppression in patients with breast cancer].
Tsukikawa S; Oikawa H; Satoh T; Morikubo M; Komoriyama H; Hagiwara M; Kanasugi K; Yamaguchi S
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):645-8. PubMed ID: 2108613
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C].
Abe Y; Ueda T; Kato T; Kohli Y
Nihon Rinsho; 1994 Jul; 52(7):1817-22. PubMed ID: 7521424
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
[TBL] [Abstract][Full Text] [Related]
8. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
[TBL] [Abstract][Full Text] [Related]
9. Mitomycin C, methotrexate, and vincristine with medroxyprogesterone acetate or prednisolone for doxorubicin resistant advanced breast cancer--a randomized control study.
Tashiro H; Nomura Y
Anticancer Res; 1995; 15(5B):2229-37. PubMed ID: 8572630
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
[TBL] [Abstract][Full Text] [Related]
11. [Randomized study of long-term adjuvant chemotherapy with Futraful and mitomycin C in gastric cancer. A second study (fourth report)].
Taguchi T; Usugane M; Inokuchi K; Hattori T; Inoue K; Kondo T; Akiyama H; Abe O; Nakajima T; Muto T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1833-9. PubMed ID: 3929692
[TBL] [Abstract][Full Text] [Related]
12. [Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer].
Abe R; Tsuchiya A; Koie H; Ono K; Abo S; Saito K; Tsukamoto M; Sato T; Mori S; Motoki R
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2707-12. PubMed ID: 3137888
[TBL] [Abstract][Full Text] [Related]
13. Long duration of response with vindesine-mitoxantrone-mitomycin (VMMc) combination chemotherapy in metastatic breast cancer: a pilot phase II study.
Belpomme D; Heritier F; Gisselbrecht C; Marty M; Michaud G; Le Rol A; Cour V; George C; Maral J
Cancer Treat Rep; 1987 Sep; 71(9):845-7. PubMed ID: 3621218
[TBL] [Abstract][Full Text] [Related]
14. [Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)].
Kasai Y; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Abe O; Ito I; Nakajima T; Muto T; Kikuchi K; Sugie S; Hayasaka A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1449-60. PubMed ID: 6820917
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.
Andersson M; Daugaard S; von der Maase H; Mouridsen HT
Cancer Treat Rep; 1986 Oct; 70(10):1181-6. PubMed ID: 3530444
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients.
Ardizzoni A; Pronzato P; Conte PF; Rosso R
Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624
[TBL] [Abstract][Full Text] [Related]
17. Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer.
Arima S; Ohsato K; Hisatsugu T; Shimura H
Eur J Surg; 1994 Apr; 160(4):227-32. PubMed ID: 8049313
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
[TBL] [Abstract][Full Text] [Related]
19. [Present status of endocrine therapy of breast cancer: a surgeon's view].
Nomura Y
Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of chemotherapeutic agents in the treatment of primary liver cancer].
Ohya T; Kikuchi S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1623-7. PubMed ID: 6191720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
